Omada Health Debt to Equity Ratio 2025-2025 | OMDA
Current and historical debt to equity ratio values for Omada Health (OMDA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Omada Health debt/equity for the three months ending September 30, 2025 was 0.00.
| Omada Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.07B | $0.22B | 0.32 |
| 2025-06-30 | $0.09B | $0.21B | 0.41 |
| 2024-12-31 | $0.54B | $-0.38B | -1.39 |
| 2024-09-30 | $0.00B | $0.00B | 0.00 |
| 2024-06-30 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.656B | $0.000B |
| Omada Health Inc. provides a range of virtual care programs principally in the United States. The company offers cardiometabolic programs for prediabetes, diabetes and hypertension; a physical therapy program to address musculoskeletal conditions other support programs. Omada Health Inc. is based in San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $155.220B | 28.17 |
| HCA Healthcare (HCA) | United States | $114.565B | 17.76 |
| CVS Health (CVS) | United States | $96.096B | 11.22 |
| Elevance Health (ELV) | United States | $71.870B | 10.79 |
| Cencora (COR) | United States | $69.838B | 22.03 |
| Natera (NTRA) | United States | $29.276B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.585B | 17.98 |
| DiDi Global (DIDIY) | China | $22.403B | 20.70 |
| Viatris (VTRS) | United States | $18.371B | 6.85 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.777B | 0.00 |
| Solventum (SOLV) | United States | $13.956B | 13.55 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.564B | 29.15 |
| CochLear (CHEOY) | Australia | $11.879B | 0.00 |
| Revvity (RVTY) | United States | $11.876B | 20.66 |
| ICON (ICLR) | Ireland | $11.673B | 11.58 |
| Charles River Laboratories (CRL) | United States | $8.920B | 17.18 |
| Sonic Healthcare (SKHHY) | Australia | $7.755B | 0.00 |
| Avantor (AVTR) | United States | $7.609B | 11.62 |
| BrightSpring Health Services (BTSG) | United States | $7.095B | 42.30 |
| HealthEquity (HQY) | United States | $6.694B | 25.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.255B | 0.00 |
| PACS (PACS) | United States | $6.182B | 37.59 |
| Bausch + Lomb (BLCO) | Canada | $6.076B | 39.88 |
| Sotera Health (SHC) | United States | $4.960B | 23.92 |
| Alignment Healthcare (ALHC) | United States | $4.128B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.058B | 19.09 |
| GeneDx Holdings (WGS) | United States | $2.740B | 48.11 |
| Establishment Labs Holdings (ESTA) | United States | $2.109B | 0.00 |
| Organon (OGN) | United States | $2.030B | 2.14 |
| Progyny (PGNY) | United States | $1.855B | 36.47 |
| Pediatrix Medical (MD) | United States | $1.811B | 10.81 |
| Surgery Partners (SGRY) | United States | $1.802B | 23.22 |
| Ardent Health (ARDT) | United States | $1.286B | 4.20 |
| InnovAge Holding (INNV) | United States | $1.136B | 167.40 |
| CareDx (CDNA) | United States | $1.058B | 17.29 |
| Teladoc Health (TDOC) | United States | $0.861B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.791B | 12.94 |
| Nutex Health (NUTX) | United States | $0.717B | 5.48 |
| Sonida Senior Living (SNDA) | United States | $0.646B | 0.00 |
| Embecta (EMBC) | United States | $0.609B | 3.40 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.604B | 0.00 |
| Enhabit (EHAB) | United States | $0.566B | 25.43 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.485B | 8.92 |
| CryoPort (CYRX) | United States | $0.436B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.393B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| So-Young (SY) | China | $0.374B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.352B | 5.67 |
| Shoulder Innovations (SI) | United States | $0.272B | 0.00 |
| Oncology Institute (TOI) | United States | $0.264B | 0.00 |
| Agilon Health (AGL) | United States | $0.187B | 0.00 |
| Beauty Health (SKIN) | United States | $0.148B | 0.00 |
| LifeMD (LFMD) | United States | $0.147B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.113B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.074B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Pomdoctor - (POM) | China | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.07 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Lifeward (LFWD) | United States | $0.010B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |